Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Operating Room

Healthcare Contracting, Regulatory & Operational

We counsel hundreds of healthcare clients on a complex set of rapidly changing regulations impacting healthcare operations which, in turn, impacts how providers deliver quality care to patients.

Our clients include hospitals and health systems of all sizes as well as specialty services including behavioral health facilities, hospitalist programs and disease management services.

We counsel hundreds of healthcare clients on a complex set of rapidly changing regulations impacting healthcare operations which, in turn, impacts how providers deliver quality care to patients.

Our clients include hospitals and health systems of all sizes as well as specialty services including behavioral health facilities, hospitalist programs and disease management services.

Critical areas in which we provide counsel include:

  • Self-referral prohibition
  • Fraud and abuse analysis
  • Licensure
  • Accreditation
  • Certificates of Need
  • Corporate compliance programs
  • Managed care contracting
  • Group purchasing arrangements
  • HIPAA compliance, and
  • Medicare, Medicaid, and third-party payor reimbursement matters.

We advise clients on the structuring of compliant financial relationships, such as:

  • Professional services agreements
  • Medical directorships
  • Co-management arrangements
  • Physician recruitment agreements
  • Medical staff bylaws
  • Staff privileges, and
  • Professional liability. 

The firm also advises on patient care issues involving:

  • Advance directives
  • Informed consent
  • Emergency Medical Treatment & Labor Act (EMTALA) transfers, and 
  • Anti-discrimination and accessibility laws. 

Further, we counsel clients on emerging areas of the law such as:

  • Forming accountable care organizations
  • Responding to the challenges and opportunities of the Affordable Care Act (ACA), and 
  • Implementing electronic health records (EHR). 

+ Read More

- Read Less

News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.